Yu Xingmei, Zhu Haiyan, Yang Xiaoyun, Lu Yanhong, Sun Huiquan, Fan Liping, Tao Hui, Zhou Jing, Luo Wei, Lai Kefang, Hao Chuangli
Department of Respiratory Diseases, Children's Hospital of Soochow University, Suzhou 215003, China.
Email:
Zhonghua Yi Xue Za Zhi. 2014 Apr 29;94(16):1215-8.
To explore the dynamic changes of airway hyperresponsiveness (AHR) in children with cough variant asthma (CVA).
A prospective observational study was conducted at the Children's Hospital of Soochow University from April 2012 to March 2013. A total of 36 patients were diagnosed as CVA. According to the integral dose of histamine resulting in a 20% (PD20) fall in forced expiratory volume in 1 s (FEV1), the severity of CVA was graded. Corresponding treatment was administered and the dynamic changes of airway hyperresponsiveness were followed for 0, 1 and 6 months.
Among them, 14 patients suffered from CVA only while another 22 cases had CVA plus upper airway cough syndrome (UACS). PD20 of CVA and CVA+UACS groups were (0.46 ± 0.26) and (0.58 ± 0.34) mg respectively. No statistically significance existed between two groups (t = -0.880, P > 0.05). According to the value of PD20, AHR in CVA patients was classified into four degrees of severe, moderate, mild and very mild. Initially there were moderate (n = 8), mild (n = 21) and very mild (n = 5). At 1 month follow-up, moderate (n = 1), mild (n = 28) and borderline (n = 7); At 6 month, moderate (n = 2), mild (n = 20) and very mild (n = 7). And 4 cases turned negative and another 3 cases became lost. Cough symptom score and PD20 showed no significant correlation (r = -0.086, P > 0.05).
AHR in CVA patients is predominantly mild and very mild. And it decreases rapidly mostly during initial treatment phase. The proportion of conversion from CVA into negative and typical bronchial asthma is relatively low.
探讨咳嗽变异性哮喘(CVA)患儿气道高反应性(AHR)的动态变化。
2012年4月至2013年3月在苏州大学附属儿童医院进行一项前瞻性观察性研究。共36例患者被诊断为CVA。根据使一秒用力呼气容积(FEV1)下降20%(PD20)的组胺累积剂量对CVA严重程度进行分级。给予相应治疗,并随访0、1和6个月时气道高反应性的动态变化。
其中,14例仅患有CVA,另外22例患有CVA合并上气道咳嗽综合征(UACS)。CVA组和CVA + UACS组的PD20分别为(0.46±0.26)mg和(0.58±0.34)mg。两组间无统计学意义(t = -0.880,P>0.05)。根据PD20值,CVA患者的AHR分为重度、中度、轻度和极轻度四个等级。初始时中度(n = 8)、轻度(n = 21)和极轻度(n = 5)。随访1个月时,中度(n = 1)、轻度(n = 28)和临界(n = 7);6个月时,中度(n = 2)、轻度(n = 20)和极轻度(n = 7)。4例转为阴性,另外3例失访。咳嗽症状评分与PD20无显著相关性(r = -0.086,P>0.05)。
CVA患者的AHR以轻度和极轻度为主。且大多在初始治疗阶段迅速下降。CVA转为阴性和典型支气管哮喘的比例相对较低。